A citation-based method for searching scientific literature

Mary E Ropka, Jennifer Wenzel, Elayne K Phillips, Mir Siadaty, John T Philbrick. Cancer Epidemiol Biomarkers Prev 2006
Times Cited: 113







List of co-cited articles
652 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Genetic testing: psychological aspects and implications.
Caryn Lerman, Robert T Croyle, Kenneth P Tercyak, Heidi Hamann. J Consult Clin Psychol 2002
175
16

What can interest tell us about uptake of genetic testing? Intention and behavior amongst smokers related to patients with lung cancer.
S C Sanderson, S C O'Neill, L A Bastian, G Bepler, C M McBride. Public Health Genomics 2010
60
20

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
11

Assessing hypothetical scenario methodology in genetic susceptibility testing analog studies: a quantitative review.
Susan Persky, Kimberly A Kaphingst, Celeste M Condit, Colleen M McBride. Genet Med 2007
67
14

Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.
Katrina Armstrong, Ellyn Micco, Amy Carney, Jill Stopfer, Mary Putt. JAMA 2005
282
10

The role of financial factors in acceptance of clinical BRCA genetic testing.
Shannon Kieran, Lois J Loescher, Kyung Hee Lim. Genet Test 2007
32
28

Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients.
Erna Claes, Gerry Evers-Kiebooms, Andrea Boogaerts, Marleen Decruyenaere, Lieve Denayer, Eric Legius. Am J Med Genet A 2003
158
9

Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women.
Hayley S Thompson, Heiddis B Valdimarsdottir, Chantal Duteau-Buck, Josephine Guevarra, Dana H Bovbjerg, Cassandra Richmond-Avellaneda, David Amarel, Diana Godfrey, Karen Brown, Kenneth Offit. Cancer Epidemiol Biomarkers Prev 2002
116
9

Factors associated with decisions about clinical BRCA1/2 testing.
K Armstrong, K Calzone, J Stopfer, G Fitzgerald, J Coyne, B Weber. Cancer Epidemiol Biomarkers Prev 2000
102
9


Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
831
8


Predictors of genetic testing decisions: a systematic review and critique of the literature.
Kate Sweeny, Arezou Ghane, Angela M Legg, Ho Phi Huynh, Sara E Andrews. J Genet Couns 2014
34
23

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
Robert C Green, Jonathan S Berg, Wayne W Grody, Sarah S Kalia, Bruce R Korf, Christa L Martin, Amy L McGuire, Robert L Nussbaum, Julianne M O'Daniel, Kelly E Ormond,[...]. Genet Med 2013
8

Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations.
Esme Finlay, Jill E Stopfer, Eric Burlingame, Katherine Goldfeder Evans, Katherine L Nathanson, Barbara L Weber, Katrina Armstrong, Timothy R Rebbeck, Susan M Domchek. Genet Test 2008
98
7

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.
Tuya Pal, Jenny Permuth-Wey, Judith A Betts, Jeffrey P Krischer, James Fiorica, Hector Arango, James LaPolla, Mitchell Hoffman, Martin A Martino, Katie Wakeley,[...]. Cancer 2005
494
7

Non-uptake of predictive genetic testing for BRCA1/2 among relatives of known carriers: attributes, cancer worry, and barriers to testing in a multicenter clinical cohort.
C Foster, D G R Evans, R Eeles, D Eccles, S Ashley, L Brooks, T Cole, J Cook, R Davidson, H Gregory,[...]. Genet Test 2004
48
14

Referral to cancer genetic counseling: are there stages of readiness?
Suzanne M O'Neill, June A Peters, Victor G Vogel, Eleanor Feingold, Wendy S Rubinstein. Am J Med Genet C Semin Med Genet 2006
39
17

Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer.
M Cappelli, L Surh, L Humphreys, S Verma, D Logan, A Hunter, J Allanson. Clin Genet 1999
91
7

Barriers and facilitators for utilization of genetic counseling and risk assessment services in young female breast cancer survivors.
Beth Anderson, Jennifer McLosky, Elizabeth Wasilevich, Sarah Lyon-Callo, Debra Duquette, Glenn Copeland. J Cancer Epidemiol 2012
61
11

Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: a vignette-based study.
Katrina F Trivers, Laura-Mae Baldwin, Jacqueline W Miller, Barbara Matthews, C Holly A Andrilla, Denise M Lishner, Barbara A Goff. Cancer 2011
76
9

Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk.
Douglas E Levy, Stacey D Byfield, Catherine B Comstock, Judy E Garber, Sapna Syngal, William H Crown, Alexandra E Shields. Genet Med 2011
152
7

Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell.
Andrea Farkas Patenaude, Michel Dorval, Lisa S DiGianni, Katherine A Schneider, Anu Chittenden, Judy E Garber. J Clin Oncol 2006
121
6

BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
599
6

Public interest in genetic testing for susceptibility to heart disease and cancer: a population-based survey in the UK.
Saskia C Sanderson, Jane Wardle, Martin J Jarvis, Steve E Humphries. Prev Med 2004
60
10

Women's interest in genetic testing for breast cancer risk: the influence of sociodemographics and knowledge.
Joan L Bottorff, Pamela A Ratner, Lynda G Balneaves, Chris G Richardson, Mary McCullum, Tom Hack, Karen Chalmers, Jane Buxton. Cancer Epidemiol Biomarkers Prev 2002
61
9

Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.
Thomas S Frank, Amie M Deffenbaugh, Julia E Reid, Mark Hulick, Brian E Ward, Beth Lingenfelter, Kathi L Gumpper, Thomas Scholl, Sean V Tavtigian, Dmitry R Pruss,[...]. J Clin Oncol 2002
628
6

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff,[...]. J Clin Oncol 2004
697
6

A systematic review of perceived risks, psychological and behavioral impacts of genetic testing.
Jodi T Heshka, Crystal Palleschi, Heather Howley, Brenda Wilson, Philip S Wells. Genet Med 2008
221
6

Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients.
Karin Landsbergen, Chris Verhaak, Floor Kraaimaat, Nicoline Hoogerbrugge. Fam Cancer 2005
53
11


Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families.
B B Biesecker, N Ishibe, D W Hadley, T R Giambarresi, R G Kase, C Lerman, J P Struewing. Am J Med Genet 2000
91
6

Decision-making about genetic testing among women at familial risk for breast cancer.
P B Jacobsen, H B Valdimarsdottier, K L Brown, K Offit. Psychosom Med 1997
128
6

Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
6

The influence of psychological distress on use of genetic testing for cancer risk.
C Lerman, M D Schwartz, T H Lin, C Hughes, S Narod, H T Lynch. J Consult Clin Psychol 1997
139
6

Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients.
Marc D Schwartz, Caryn Lerman, Barbara Brogan, Beth N Peshkin, Claudine Isaacs, Tiffani DeMarco, Chanita Hughes Halbert, Marie Pennanen, Clinton Finch. Cancer Epidemiol Biomarkers Prev 2005
66
9


Prevalence and healthcare actions of women in a large health system with a family history meeting the 2005 USPSTF recommendation for BRCA genetic counseling referral.
Cecelia A Bellcross, Steven Leadbetter, Sharon Hensley Alford, Lucy A Peipins. Cancer Epidemiol Biomarkers Prev 2013
41
14

Factors associated with an individual's decision to withdraw from genetic testing for breast and ovarian cancer susceptibility: implications for counseling.
Béatrice Godard, Annabelle Pratte, Martine Dumont, Adèle Simard-Lebrun, Jacques Simard. Genet Test 2007
33
18

Decision making and decision support for hereditary breast-ovarian cancer susceptibility.
Marc D Schwartz, Beth N Peshkin, Kenneth P Tercyak, Kathryn L Taylor, Heiddis Valdimarsdottir. Health Psychol 2005
47
10

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
D Ford, D F Easton, D T Bishop, S A Narod, D E Goldgar. Lancet 1994
5



Psychological consequences of predictive genetic testing: a systematic review.
M Broadstock, S Michie, T Marteau. Eur J Hum Genet 2000
235
5

Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
Michael J Green, Susan K Peterson, Maria Wagner Baker, Gregory R Harper, Lois C Friedman, Wendy S Rubinstein, David T Mauger. JAMA 2004
216
5

Genetic counseling and testing in families with hereditary nonpolyposis colorectal cancer.
Donald W Hadley, Jean Jenkins, Eileen Dimond, Kenneth Nakahara, Liam Grogan, David J Liewehr, Seth M Steinberg, Ilan Kirsch. Arch Intern Med 2003
119
5

Validation of a decisional conflict scale.
A M O'Connor. Med Decis Making 1995
5

Testing participation in BRCA1/2-positive families: initiator role of index cases.
Cécile Blandy, Françoise Chabal, Dominique Stoppa-Lyonnet, Claire Julian-Reynier. Genet Test 2003
44
11

International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.
Kelly A Metcalfe, Daphna Birenbaum-Carmeli, Jan Lubinski, Jacek Gronwald, Henry Lynch, Pal Moller, Parviz Ghadirian, William D Foulkes, Jan Klijn, Eitan Friedman,[...]. Int J Cancer 2008
241
5

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.